Thomas Spitznagel - 15 Feb 2024 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Sr VP, Technical Ops
Signature
/s/ Lynn M. Cilinski, Attorney-in-fact
Issuer symbol
MGNX
Transactions as of
15 Feb 2024
Net transactions value
-$87,348
Form type
4
Filing time
20 Feb 2024, 18:03:54 UTC
Previous filing
12 Feb 2024
Next filing
06 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $0 +13,336 $0.000000 13,336 15 Feb 2024 Direct F1
transaction MGNX Common Stock Tax liability $87,348 -5,020 -38% $17.40 8,316 15 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -13,336 -33% $0.000000 26,664 15 Feb 2024 Common Stock 13,336 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 15, 2023 the reporting person was granted 40,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.